Funder
Lottery Health Research
Canterbury Medical Health Foundation
University of Otago
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V, Preisig M, Malhotra A, Waeber G, Vollenweider P, Tafti M, Haba-Rubio J (2015) Prevalance of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med 3:310–318. https://doi.org/10.1016/S2213-2600(15)00043-0
2. Thomas RJ, Chan S (2013) Neuroimaging of cognitive effects in obstructive sleep apnea. In: Maquet P, Thorpy MJ (eds) Nofzinger E. Neuroimaging of Sleep and Sleep Disorders, Cambridge University Press, pp 264–274
3. Mullins AE, Kam K, Parekh A, Bubu OM, Osorio RS, Varga AW (2020) Obstructive sleep apnea and its treatment in aging: Effects on Alzheimer’s disease biomarkers, cognition, brain structure and neurophysiology. Neurobiol Dis 145:105054. https://doi.org/10.1016/j.nbd.2020.105054
4. Daulatzai MA (2015) Evidence of neurodegeneration in obstructive sleep apnea: Relationship between obstructive sleep apnea and cognitive dysfunction in the elderly. J Neurosci Res 93:1778–1794. https://doi.org/10.1002/jnr.23634
5. Joo EY, Tae WS, Han SJ, Cho J-W, Hong SB (2007) Reduced cerebral blood flow during wakefulness in obstructive sleep apnea-hypopnea syndrome. Sleep 30:1515–1520. https://doi.org/10.1093/sleep/30.11.1515